4699

GlaxoSmithKline paid 10 million to settle multistate litigation alleging that the company violated the False Claims Act through fraudulent drug pricing and marketing of two anti-emetic drugs, Zofran and Kytril, used primarily in conjunction with oncology and radiation treatment. This was part of a larger 150 million settlement involving the federal government; ###-glaxosmithkline